The Women's Cancer Developmental Therapeutics Program (WCDTP) seeks to increase the development of novel cancer therapies in Gynecologic and Breast cancers, leading to a decrease in cancer-related morbidity and mortality for patients. Additionally, the WCTD seeks to increase access to Phase I/II clinical trials of novel cancer therapies for patients with Gynecologic and Breast cancers.
Breast, Endometrial, Ovarian, Fallopian tube, Peritoneal, Cervical, Vulvar, and Vaginal.
To increase the development of novel cancer therapies in Gynecologic and Breast cancers, leading to a decrease in cancer-related morbidity and mortality for patients. Increase access to Phase I/II clinical trials of novel cancer therapies for patients with Gynecologic and Breast cancers.
Name | Title | Speciality |
Jennifer Diamond, MD | Co-Director | Medical Oncology |
Christine Fisher, MD | Co-Director | Radiation Oncology |
Bradley Corr, MD | Lead Gynecologic Oncologist | Gynecologic Oncology |
Peter Kabos, MD | Translational Research Lead | Medical Oncology |
P: 720-848-9302
Anschutz Cancer Pavilion
1665 Aurora Court
Aurora, CO 80045